![](https://cdn.sanity.io/images/0vv8moc6/genetherapy/fa518c45b50a778efdb35b0fbf0b04cf6370a26b-1200x1029.jpg?fit=crop&auto=format)
Anixa Biosciences Secures FDA Clearance to Redose Single Patient in Ovarian Cancer CER-T Trial
Anixa Biosciences, via its partner Moffitt Cancer Center, has received clearance of a individual patient investigational new drug (IND) application from the FDA, allowing Moffitt to administer a second dose of Anixa's novel follicle stimulating hormone …